Phosphoric Acid

Phosphoric Acid

SCHEMBL3476886

N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)O.O=P(O)(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 1/20 0.49
KCNH2 known ✓ Q12809 1/20 0.49
PTPRC P08575 1/20 0.56
SLC7A5 Q01650 3/20 0.56
PTPN1 P18031 2/20 0.55
PTGS1 P23219 3/20 0.54
ALPI P09923 1/20 0.54
PKM P14618 1/20 0.54
XIAP P98170 1/20 0.54
ITGB3 P05106 1/20 0.54
ITGA2B P08514 1/20 0.54
HIF1A Q16665 5/20 0.49
CYP3A4 P08684 3/20 0.49
ALOX15 P16050 3/20 0.49
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL27545043 1.00 PTPRC (0.56) PTPRCSLC7A5PTPN1PTGS1ALPI
SCHEMBL273663 0.98 PTPRC (0.57) PTPRCSLC7A5PTPN1PTGS1ALPI
SCHEMBL4066744 0.98 PTPRC (0.57) PTPRCSLC7A5PTPN1PTGS1ALPI
SCHEMBL3626587 0.98 PTPRC (0.57) PTPRCSLC7A5PTPN1PTGS1ALPI
SCHEMBL1152 0.98 PTPRC (0.57) PTPRCSLC7A5PTPN1PTGS1ALPI
SCHEMBL29567635 0.97 PTPRC (0.56) PTPRCSLC7A5PTPN1PTGS1ALPI
SCHEMBL27947556 0.97 PTPRC (0.56) PTPRCSLC7A5PTPN1PTGS1ALPI
SCHEMBL19615883 0.97 PTPRC (0.56) PTPRCSLC7A5PTPN1PTGS1ALPI
SCHEMBL29613927 0.97 PTPRC (0.56) PTPRCSLC7A5PTPN1PTGS1ALPI
Phosphine SCHEMBL28192584 0.97 PTPRC (0.56) PTPRCSLC7A5PTPN1PTGS1ALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7769575-B2 Three dimensional coordinates of HPTPbeta Warner Chilcott, LLC (US) 2010-08-03 US disclosed
US-20100030487-A1 THREE DIMENSIONAL COORDINATES OF HPTPbeta Aerpio Pharmaceuticals, Inc. 2010-02-04 US disclosed
US-7507568-B2 Three dimensional coordinates of HPTPbeta THE PROCTOR & GAMBLE COMPANY (US) 2009-03-24 US disclosed
CN-1812782-A Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors ACTELION PHARMACEUTICALS LTD (CH) 2006-08-02 CN disclosed
US-20060014932-A1 Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same VANDERBILT UNIVERSITY 2006-01-19 US disclosed
US-6939952-B2 Purified and isolated protein zero related (PZR) polypeptide VANDERBILT UNIVERSITY (US) 2005-09-06 US disclosed
US-20040077065-A1 Three dimensional coordinates of HPTPbeta THE PROCTER & GAMBLE COMPANY 2004-04-22 US disclosed
US-20030171565-A1 Modulating cell signaling, detecting tyrosine kinase or tyrosine phosphatase biological activity NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-09-11 US disclosed
US-6355786-B1 A NUCLEIC ACID ENCODING A TRANSMEMBRANE PROTEIN THAT BINDS TYROSINE PHOSPHATASE-2; DIAGNOSIS AND THERAPY FOR PROLIFERATIVE AND DIFFERENTIATION DISORDERS; THERAPY FOR TYPE 1B CHARCOT-MARIE TOOTH DISORDER VANDERBILT UNIVERSITY 2002-03-12 US disclosed